By incorporating the expression levels of CDH6, EGFLAM, and RASGRF2, along with age, gender, stage, and grade, we effectively developed a prognostic nomogram for anticipating the overall survival of STAD patients. The gene discussed is CDH6; the disease is gastric adenocarcinoma.